US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AN2 Therapeutics, Inc.

1.15

-0.0500-4.17%

Post-market: 1.170.0200+1.74%19:01 EDT

Volume:1.42M

Turnover:1.61M

Market Cap:34.61M

PE:-0.67

High:1.18

Open:1.17

Low:1.05

Close:1.20

Loading ...

Overview Company News Filings

AN2 Provides Strategic Update for Phase 3 Ebo-301 Trial in Treatment Refractory Mac Lung Disease

THOMSON REUTERS

AN2 Therapeutics Inc: to Release Topline Phase 3 Results for Ebo-301 in Q2 of 2025

THOMSON REUTERS

AN2 Provides Strategic Update for Phase 3 EBO-301 Trial in Treatment Refractory MAC Lung Disease

AN2 Therapeutics to Participate at Upcoming Investor Conferences

AN2 Therapeutics, Inc. (ANTX) Gets a Buy from JMP Securities

Evercore ISI Keeps Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)

AN2 Therapeutics Price Target Maintained With a $5.00/Share by JMP Securities

AN2 Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Recursion Pharmaceuticals (RXRX) and AN2 Therapeutics, Inc. (ANTX)

TD Cowen Downgrades AN2 Therapeutics to Hold From Buy

MT Newswires Live

AN2 Therapeutics, Inc. (ANTX) Receives a Sell from Evercore ISI

AN2 Therapeutics to Meet With FDA on Epetraborole Development Path

AN2 Therapeutics Q3 EPS $(0.43) Beats $(0.54) Estimate

AN2 Therapeutics- Cash, Cash Equivalents of $93.4 Mln at Sept 30 Anticipated to Fund Operations Through 2027 Under Current Operating Plan

THOMSON REUTERS

Press Release: AN2 Therapeutics Reports Third Quarter 2024 Financial Results, Provides Important EBO-301 Update and Highlights Progress Across Boron Chemistry Pipeline

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ANTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","market":"US","secType":"STK","nameCN":"AN2 Therapeutics, Inc.","latestPrice":1.15,"timestamp":1746561600000,"preClose":1.2,"halted":0,"volume":1419927,"hourTrading":{"tag":"盘后","latestPrice":1.17,"preClose":1.15,"latestTime":"19:01 EDT","volume":107,"amount":125.26,"timestamp":1746572470628},"delay":0,"floatShares":17669814,"shares":30098720,"eps":-1.720551,"marketStatus":"Closed","change":-0.05,"latestTime":"05-06 16:00:00 EDT","open":1.165,"high":1.18,"low":1.05,"amount":1611048.6062292,"amplitude":0.108333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.720551,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746604800000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1648180800000,"exchange":"NASDAQ","adjPreClose":1.2,"preHourTrading":{"tag":"盘前","latestPrice":1.2,"preClose":1.21,"latestTime":"08:30 EDT","volume":2,"amount":2.4,"timestamp":1746534641609},"postHourTrading":{"tag":"盘后","latestPrice":1.17,"preClose":1.15,"latestTime":"19:01 EDT","volume":107,"amount":125.26,"timestamp":1746572470628},"volumeRatio":17.082609},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","floatShares":17669814,"roa":"-29.54%","roe":"-49.69%","lyrEps":-1.720551,"volumeRatio":17.082609,"shares":30098720,"dividePrice":2.625,"high":1.18,"amplitude":0.108333,"preClose":1.2,"low":1.05,"week52Low":0.87,"pbRate":"0.42","week52High":3.07,"institutionHeld":0,"latestPrice":1.15,"eps":-1.720551,"divideRate":2.282609,"volume":1419927,"delay":0,"ttmEps":-1.720551,"open":1.165,"prevYearClose":1.38,"prevWeekClose":1.22,"prevMonthClose":1.24,"prevQuarterClose":1.36,"fiveDayClose":1.22,"twentyDayClose":1.24,"sixtyDayClose":1.08},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2513740698","title":"AN2 Provides Strategic Update for Phase 3 Ebo-301 Trial in Treatment Refractory Mac Lung Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2513740698","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513740698?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA4LXLQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2513402728","title":"AN2 Therapeutics Inc: to Release Topline Phase 3 Results for Ebo-301 in Q2 of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2513402728","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513402728?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA4LXLQY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2513772808","title":"AN2 Provides Strategic Update for Phase 3 EBO-301 Trial in Treatment Refractory MAC Lung Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2513772808","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513772808?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398400,"startTime":"0","endTime":"0","summary":"AN2 Selects QOL-B as New Phase 3 Primary Efficacy Endpoint. Goal to Accelerate Unblinding Phase 3 Data in Q2 2025 Ahead of Potential FDA Meeting. \"In Phase 2, we observed potentially meaningful clinical improvement in a highly refractory population. The FDA has made it clear that the primary bar for NTM drug approval is patient-reported improvement in NTM symptoms. Our recent statistical analysis plan submission provides the opportunity to seek FDA input on our selection of QOL-B as the new primary efficacy endpoint prior to unblinding the Phase 3 data and requesting a formal meeting,\" said Eric Easom, Co-Founder, President and Chief Executive Officer. \"Should the Phase 3 data confirm the Phase 2 findings, we plan to meet with the FDA to discuss potential registrational pathways in this highly refractory population with minimal to no treatment options.\". FDA’s 2023 Guidance for Industry on NTM drug development recommends PRO-based clinical outcome measures as the primary efficacy endpo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/an2-provides-strategic-phase-3-120000435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRO","BK4080","BK4551","BK4007","BK4023","BK4231","ANTX","MAC"],"gpt_icon":0},{"id":"2512044915","title":"AN2 Therapeutics to Participate at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2512044915","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512044915?lang=en_us&edition=fundamental","pubTime":"2025-02-20 20:00","pubTimestamp":1740052800,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., February 20, 2025----AN2 Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that company management will participate in two upcoming investor conferences in March.Eric Easom, Co-Founder, Chairman, President and CEO will provide a corporate overview on Monday, March 3, 2025 at 2:30 pm ET, and members of management will be available for 1X1 meetings.Members of management will be available for 1X1 meetings on Wednesday, March 12, 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/an2-therapeutics-participate-upcoming-investor-120000325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANTX","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2512495268","title":"AN2 Therapeutics, Inc. (ANTX) Gets a Buy from JMP Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2512495268","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512495268?lang=en_us&edition=fundamental","pubTime":"2025-02-20 14:05","pubTimestamp":1740031520,"startTime":"0","endTime":"0","summary":"JMP Securities analyst Roy Buchanan reiterated a Buy rating on AN2 Therapeutics, Inc. (ANTX – Research Report) today and set a price target of $5.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/an2-therapeutics-inc-antx-gets-a-buy-from-jmp-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/an2-therapeutics-inc-antx-gets-a-buy-from-jmp-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JMP","ANTX","BK4127","BK4007"],"gpt_icon":0},{"id":"2510820135","title":"Evercore ISI Keeps Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2510820135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510820135?lang=en_us&edition=fundamental","pubTime":"2025-02-11 14:36","pubTimestamp":1739255786,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Sell rating on AN2 Therapeutics, Inc. (ANTX – Research Report), with a p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evercore-isi-keeps-their-sell-rating-on-an2-therapeutics-inc-antx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evercore-isi-keeps-their-sell-rating-on-an2-therapeutics-inc-antx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANTX"],"gpt_icon":0},{"id":"2508459131","title":"AN2 Therapeutics Price Target Maintained With a $5.00/Share by JMP Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2508459131","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508459131?lang=en_us&edition=fundamental","pubTime":"2025-02-03 22:06","pubTimestamp":1738591560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 03, 2025 09:06 ET (14:06 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ANTX","JMP"],"gpt_icon":0},{"id":"2507982665","title":"AN2 Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2507982665","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507982665?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:00","pubTimestamp":1738184400,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., January 29, 2025----AN2 Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO, will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference.Eric Easom, Co-Founder, Chairman, President and CEO will provide a corporate overview on Wednesday, February 12, 2025 at 3:20pm ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/an2-therapeutics-present-oppenheimer-35th-210000880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4139","ANTX","BK4007","HCSG","BK4137","OPY","BK4127"],"gpt_icon":0},{"id":"2486203207","title":"Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Recursion Pharmaceuticals (RXRX) and AN2 Therapeutics, Inc. (ANTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2486203207","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486203207?lang=en_us&edition=fundamental","pubTime":"2024-11-25 14:00","pubTimestamp":1732514438,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Vor Biopharma (VOR – Research Report), Recursion P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vor-biopharma-vor-recursion-pharmaceuticals-rxrx-and-an2-therapeutics-inc-antx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vor-biopharma-vor-recursion-pharmaceuticals-rxrx-and-an2-therapeutics-inc-antx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4137","VOR","HCSG","ANTX","BK4548","BK4007","RXRX","BK4139"],"gpt_icon":0},{"id":"2484494621","title":"TD Cowen Downgrades AN2 Therapeutics to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2484494621","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484494621?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:39","pubTimestamp":1731933559,"startTime":"0","endTime":"0","summary":"TD Cowen Downgrades AN2 Therapeutics to Hold From Buy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TD","LENZ","COWN","ANTX"],"gpt_icon":0},{"id":"2483877674","title":"AN2 Therapeutics, Inc. (ANTX) Receives a Sell from Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2483877674","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483877674?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:02","pubTimestamp":1731589370,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Liisa Bayko maintained a Sell rating on AN2 Therapeutics, Inc. (ANTX – Research Report) today and set a price target of $2.00....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/an2-therapeutics-inc-antx-receives-a-sell-from-evercore-isi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/an2-therapeutics-inc-antx-receives-a-sell-from-evercore-isi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2483866367","title":"AN2 Therapeutics to Meet With FDA on Epetraborole Development Path","url":"https://stock-news.laohu8.com/highlight/detail?id=2483866367","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483866367?lang=en_us&edition=fundamental","pubTime":"2024-11-14 06:06","pubTimestamp":1731535560,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics said it was planning to meet with the U.S. Food and Drug Administration to discuss a development path for epetraborole, a treatment of non-tuberculous mycobacterial lung disease.The company said it will seek an End-of-Phase 2 meeting with the FDA in the first half of next year, and expects to leverage insights from Phase 2 results to evaluate potential reinitiation of a Phase 3 study. AN2 also said it will seek to align with the agency on a statistical analysis plan for 97 patients who completed six months of treatment in a trial which was halted August. The company said it expects to release top-line Phase 3 data from these patients in mid-2025, subject to the timing of discussions with the FDA.Eric Easom, the company's co-founder, chairman, president and chief executive officer, said recent data analysis indicate that epetraborole may provide clinical improvement in patients with treatment-refractory MAC lung disease.The company said epetraborole is the first drug ca","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ANTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2483501428","title":"AN2 Therapeutics Q3 EPS $(0.43) Beats $(0.54) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483501428","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483501428?lang=en_us&edition=fundamental","pubTime":"2024-11-14 05:01","pubTimestamp":1731531718,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.54) by 20.37 percent. This is a 33.85 percent increase over losses of $(0.65) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41953703/an2-therapeutics-q3-eps-0-43-beats-0-54-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ANTX"],"gpt_icon":0},{"id":"2483682698","title":"AN2 Therapeutics- Cash, Cash Equivalents of $93.4 Mln at Sept 30 Anticipated to Fund Operations Through 2027 Under Current Operating Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2483682698","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483682698?lang=en_us&edition=fundamental","pubTime":"2024-11-14 05:00","pubTimestamp":1731531600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUA25G15M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2483850170","title":"Press Release: AN2 Therapeutics Reports Third Quarter 2024 Financial Results, Provides Important EBO-301 Update and Highlights Progress Across Boron Chemistry Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2483850170","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483850170?lang=en_us&edition=fundamental","pubTime":"2024-11-14 05:00","pubTimestamp":1731531600,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Reports Third Quarter 2024 Financial Results, Provides Important EBO-301 Update and Highlights Progress Across Boron Chemistry Pipeline. Epetraborole-treated patients demonstrated clinical improvements in QOL-B and a post-hoc analysis of MACrO with nominal statistical significance when evaluated as continuous measures. First drug candidate with statistically favorable patient reported outcome -based improvement in treatment-refractory Mycobacterium avium Complex  population. Company plans to meet with FDA to gain alignment on a development path for epetraborole, including potentially reinitiating a Phase 3 clinical study, while advancing its boron chemistry pipeline. Achieved 50% reduction in expenditures through strategic realignment of operations. Cash, cash equivalents, and investments of $93.4 million at September 30, 2024 anticipated to fund operations through 2027 under current operating plan. AN2 Therapeutics, Inc. , a biopharmaceutical company focused on discov","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRO","BK4023","BK4213","PRGS","SOC","BK4139","ANTX","BK4007","BK4097","LENZ","LU2065732104.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":35,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANTX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.2,"hold":0.6,"sell":0.2,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6,"analysts":5,"updateTime":1736481600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANTX","date":"2025-05-05","current":-0.715505,"percent":0.808256,"low":-16.371108,"twenty":-8.476635,"median":-4.443127,"eighty":-0.727235,"high":-0.452319,"avg":-4.805443,"sd":3.943237,"marketCap":36720438},"quantilePoints":[{"date":"2022-03-25","current":-13.396124,"twenty":-13.256944,"median":-13.048173,"eighty":-12.797512,"marketCap":288592704},{"date":"2022-04-01","current":-13.735377,"twenty":-13.389165,"median":-13.082968,"eighty":-13.048173,"marketCap":295901220},{"date":"2022-04-08","current":-13.126462,"twenty":-13.389165,"median":-13.126462,"eighty":-13.048173,"marketCap":282783370},{"date":"2022-04-14","current":-12.195692,"twenty":-13.35611,"median":-13.056872,"eighty":-12.282634,"marketCap":262731799},{"date":"2022-04-22","current":-12.674125,"twenty":-13.265642,"median":-13.043824,"eighty":-12.188734,"marketCap":273038682},{"date":"2022-04-29","current":-13.596196,"twenty":-13.35611,"median":-13.048173,"eighty":-12.282634,"marketCap":292902855},{"date":"2022-05-06","current":-16.371108,"twenty":-13.735377,"median":-13.082968,"eighty":-12.639148,"marketCap":352682772},{"date":"2022-05-13","current":-12.634954,"twenty":-13.707541,"median":-13.048173,"eighty":-12.337661,"marketCap":343038993},{"date":"2022-05-20","current":-7.432326,"twenty":-13.556182,"median":-13.043824,"eighty":-12.180035,"marketCap":201787643},{"date":"2022-05-27","current":-10.426695,"twenty":-13.392645,"median":-13.013378,"eighty":-11.61546,"marketCap":283084780},{"date":"2022-06-03","current":-11.20566,"twenty":-13.378727,"median":-12.769812,"eighty":-10.726847,"marketCap":304233677},{"date":"2022-06-10","current":-6.882048,"twenty":-13.265642,"median":-12.632679,"eighty":-9.433336,"marketCap":186847596},{"date":"2022-06-17","current":-6.081643,"twenty":-13.265642,"median":-12.334802,"eighty":-8.368513,"marketCap":165116619},{"date":"2022-06-24","current":-6.253159,"twenty":-13.196052,"median":-12.186994,"eighty":-7.795366,"marketCap":169773257},{"date":"2022-07-01","current":-5.831517,"twenty":-13.172482,"median":-12.113054,"eighty":-7.105018,"marketCap":158325689},{"date":"2022-07-08","current":-6.424674,"twenty":-13.15991,"median":-11.715613,"eighty":-6.370361,"marketCap":174429895},{"date":"2022-07-15","current":-6.360356,"twenty":-13.1369,"median":-11.019852,"eighty":-6.253159,"marketCap":172683656},{"date":"2022-07-22","current":-5.881542,"twenty":-13.116023,"median":-10.573198,"eighty":-6.184553,"marketCap":159683875},{"date":"2022-07-29","current":-6.117376,"twenty":-13.077749,"median":-9.433336,"eighty":-5.990169,"marketCap":166086752},{"date":"2022-08-05","current":-7.28225,"twenty":-13.051653,"median":-8.550748,"eighty":-5.92728,"marketCap":197713085},{"date":"2022-08-12","current":-11.654946,"twenty":-13.048173,"median":-8.368513,"eighty":-5.964441,"marketCap":376023512},{"date":"2022-08-19","current":-11.973683,"twenty":-13.048173,"median":-8.836607,"eighty":-5.990169,"marketCap":386306920},{"date":"2022-08-26","current":-9.447843,"twenty":-13.042954,"median":-9.447843,"eighty":-6.034477,"marketCap":304815757},{"date":"2022-09-02","current":-7.685769,"twenty":-13.039474,"median":-9.296256,"eighty":-6.073067,"marketCap":247965969},{"date":"2022-09-09","current":-5.683139,"twenty":-13.031725,"median":-8.930422,"eighty":-5.955866,"marketCap":183355118},{"date":"2022-09-16","current":-5.310277,"twenty":-13.017412,"median":-8.532882,"eighty":-5.851527,"marketCap":171325470},{"date":"2022-09-23","current":-6.735572,"twenty":-12.958334,"median":-8.22201,"eighty":-5.820083,"marketCap":217309769},{"date":"2022-09-30","current":-10.452165,"twenty":-12.87166,"median":-8.485618,"eighty":-5.827229,"marketCap":337218196},{"date":"2022-10-07","current":-10.758874,"twenty":-12.827224,"median":-8.662429,"eighty":-5.851527,"marketCap":347113551},{"date":"2022-10-14","current":-10.75286,"twenty":-12.732811,"median":-9.159176,"eighty":-5.887259,"marketCap":346919525},{"date":"2022-10-21","current":-9.868816,"twenty":-12.676035,"median":-9.377444,"eighty":-5.901552,"marketCap":318397617},{"date":"2022-10-28","current":-9.056939,"twenty":-12.658457,"median":-9.321551,"eighty":-5.921562,"marketCap":292204029},{"date":"2022-11-04","current":-9.604204,"twenty":-12.633134,"median":-9.294488,"eighty":-5.955866,"marketCap":309860448},{"date":"2022-11-11","current":-7.870305,"twenty":-12.51788,"median":-9.213301,"eighty":-5.98731,"marketCap":288517524},{"date":"2022-11-18","current":-6.891148,"twenty":-12.343378,"median":-9.131888,"eighty":-6.021613,"marketCap":252622607},{"date":"2022-11-25","current":-5.8326,"twenty":-12.30698,"median":-9.032884,"eighty":-5.94729,"marketCap":213817291},{"date":"2022-12-02","current":-5.102202,"twenty":-12.193952,"median":-8.756244,"eighty":-5.842388,"marketCap":187041623},{"date":"2022-12-09","current":-4.726417,"twenty":-12.185254,"median":-8.550748,"eighty":-5.80579,"marketCap":173265735},{"date":"2022-12-16","current":-5.181593,"twenty":-12.178295,"median":-8.404872,"eighty":-5.725749,"marketCap":189952021},{"date":"2022-12-23","current":-5.043982,"twenty":-12.152199,"median":-8.130215,"eighty":-5.685509,"marketCap":184907330},{"date":"2022-12-30","current":-5.043982,"twenty":-12.047813,"median":-8.043349,"eighty":-5.617123,"marketCap":184907330},{"date":"2023-01-06","current":-5.361546,"twenty":-11.988509,"median":-7.887149,"eighty":-5.544229,"marketCap":196548925},{"date":"2023-01-13","current":-5.642062,"twenty":-11.900765,"median":-7.790914,"eighty":-5.514548,"marketCap":206832334},{"date":"2023-01-20","current":-5.292741,"twenty":-11.857841,"median":-7.780329,"eighty":-5.486455,"marketCap":194026580},{"date":"2023-01-27","current":-6.652975,"twenty":-11.83416,"median":-7.52668,"eighty":-5.481434,"marketCap":243891411},{"date":"2023-02-03","current":-8.256675,"twenty":-11.724707,"median":-7.50379,"eighty":-5.486455,"marketCap":302681464},{"date":"2023-02-10","current":-7.621547,"twenty":-11.591193,"median":-7.550498,"eighty":-5.497097,"marketCap":279398275},{"date":"2023-02-17","current":-7.224591,"twenty":-11.42481,"median":-7.520984,"eighty":-5.503782,"marketCap":264846281},{"date":"2023-02-24","current":-6.409509,"twenty":-11.289301,"median":-7.50379,"eighty":-5.509499,"marketCap":234966188},{"date":"2023-03-03","current":-5.456816,"twenty":-11.208214,"median":-7.426374,"eighty":-5.509499,"marketCap":200041403},{"date":"2023-03-10","current":-4.578221,"twenty":-11.173685,"median":-7.303982,"eighty":-5.480511,"marketCap":167832991},{"date":"2023-03-17","current":-4.684075,"twenty":-11.125722,"median":-7.239128,"eighty":-5.439451,"marketCap":171713523},{"date":"2023-03-24","current":-5.493865,"twenty":-11.125722,"median":-7.16076,"eighty":-5.330785,"marketCap":201399590},{"date":"2023-03-31","current":-4.675853,"twenty":-11.084828,"median":-7.064148,"eighty":-5.270511,"marketCap":191504234},{"date":"2023-04-06","current":-4.230534,"twenty":-11.023486,"median":-6.924927,"eighty":-5.260984,"marketCap":173265735},{"date":"2023-04-14","current":-4.216321,"twenty":-11.019852,"median":-6.821303,"eighty":-5.202027,"marketCap":172683656},{"date":"2023-04-21","current":-4.007874,"twenty":-10.916914,"median":-6.735572,"eighty":-5.163355,"marketCap":164146486},{"date":"2023-04-28","current":-3.789856,"twenty":-10.785335,"median":-6.531871,"eighty":-5.110953,"marketCap":155217351},{"date":"2023-05-04","current":-2.741598,"twenty":-10.756468,"median":-6.516471,"eighty":-5.079973,"marketCap":112284892},{"date":"2023-05-12","current":-2.021591,"twenty":-10.742455,"median":-6.4889,"eighty":-5.044655,"marketCap":98297847},{"date":"2023-05-19","current":-3.128272,"twenty":-10.723989,"median":-6.417091,"eighty":-5.017615,"marketCap":152109119},{"date":"2023-05-26","current":-2.225348,"twenty":-10.658392,"median":-6.345996,"eighty":-4.977293,"marketCap":108205337},{"date":"2023-06-02","current":-2.385158,"twenty":-10.566429,"median":-6.281745,"eighty":-4.901078,"marketCap":115975918},{"date":"2023-06-09","current":-2.560948,"twenty":-10.530346,"median":-6.253159,"eighty":-4.858736,"marketCap":124523557},{"date":"2023-06-16","current":-2.916525,"twenty":-10.482234,"median":-6.179275,"eighty":-4.763467,"marketCap":141813099},{"date":"2023-06-23","current":-2.816644,"twenty":-10.458179,"median":-6.099509,"eighty":-4.692657,"marketCap":136956486},{"date":"2023-06-30","current":-3.356001,"twenty":-10.436883,"median":-6.046964,"eighty":-4.666378,"marketCap":163182196},{"date":"2023-07-07","current":-3.515811,"twenty":-10.412827,"median":-5.988739,"eighty":-4.546389,"marketCap":170952777},{"date":"2023-07-14","current":-3.096311,"twenty":-10.358348,"median":-5.938714,"eighty":-4.379111,"marketCap":150555003},{"date":"2023-07-21","current":-3.096311,"twenty":-10.284978,"median":-5.895835,"eighty":-4.25703,"marketCap":150555003},{"date":"2023-07-28","current":-3.268106,"twenty":-10.193567,"median":-5.832059,"eighty":-4.205213,"marketCap":158908377},{"date":"2023-08-04","current":-3.216168,"twenty":-10.158686,"median":-5.817224,"eighty":-4.029666,"marketCap":156382938},{"date":"2023-08-11","current":-3.356001,"twenty":-10.014353,"median":-5.791146,"eighty":-3.845856,"marketCap":163182196},{"date":"2023-08-18","current":-5.688753,"twenty":-9.981877,"median":-5.731467,"eighty":-3.79935,"marketCap":308944792},{"date":"2023-08-25","current":-8.204932,"twenty":-9.916927,"median":-5.791146,"eighty":-3.845856,"marketCap":445593450},{"date":"2023-09-01","current":-8.226812,"twenty":-9.859194,"median":-5.817224,"eighty":-3.898925,"marketCap":446781699},{"date":"2023-09-08","current":-8.50578,"twenty":-9.820705,"median":-5.831517,"eighty":-3.974712,"marketCap":461931876},{"date":"2023-09-15","current":-7.915024,"twenty":-9.604204,"median":-5.888688,"eighty":-4.007874,"marketCap":429849148},{"date":"2023-09-22","current":-7.554007,"twenty":-9.586163,"median":-5.938714,"eighty":-4.029192,"marketCap":410243036},{"date":"2023-09-29","current":-8.730048,"twenty":-9.561973,"median":-5.988739,"eighty":-4.031561,"marketCap":474111430},{"date":"2023-10-06","current":-8.292451,"twenty":-9.447843,"median":-6.060204,"eighty":-4.121573,"marketCap":450346446},{"date":"2023-10-13","current":-8.068183,"twenty":-9.447843,"median":-6.108187,"eighty":-4.154735,"marketCap":438166892},{"date":"2023-10-20","current":-7.958784,"twenty":-9.433336,"median":-6.21897,"eighty":-4.202436,"marketCap":432225646},{"date":"2023-10-27","current":-8.062713,"twenty":-9.388622,"median":-6.246012,"eighty":-4.20799,"marketCap":437869830},{"date":"2023-11-03","current":-8.204932,"twenty":-9.299901,"median":-6.263879,"eighty":-4.222006,"marketCap":445593450},{"date":"2023-11-10","current":-8.42373,"twenty":-9.245776,"median":-6.345996,"eighty":-4.238114,"marketCap":457475942},{"date":"2023-11-17","current":-8.188416,"twenty":-9.191651,"median":-6.417091,"eighty":-4.251835,"marketCap":488651941},{"date":"2023-11-24","current":-8.592106,"twenty":-9.159176,"median":-6.462436,"eighty":-4.25703,"marketCap":512742511},{"date":"2023-12-01","current":-8.756572,"twenty":-9.148261,"median":-6.515364,"eighty":-4.263696,"marketCap":522557188},{"date":"2023-12-08","current":-9.369582,"twenty":-9.256601,"median":-6.592423,"eighty":-4.286376,"marketCap":559139166},{"date":"2023-12-15","current":-10.181945,"twenty":-9.420585,"median":-6.735572,"eighty":-4.378104,"marketCap":607617721},{"date":"2023-12-22","current":-10.216831,"twenty":-9.539147,"median":-6.886598,"eighty":-4.40653,"marketCap":609699622},{"date":"2023-12-29","current":-10.416184,"twenty":-9.612102,"median":-6.924927,"eighty":-4.479724,"marketCap":621596200},{"date":"2024-01-05","current":-9.638708,"twenty":-9.641698,"median":-7.064148,"eighty":-4.516825,"marketCap":575199546},{"date":"2024-01-12","current":-10.431136,"twenty":-9.849572,"median":-7.123402,"eighty":-4.535879,"marketCap":622488443},{"date":"2024-01-19","current":-9.892883,"twenty":-9.923734,"median":-7.161078,"eighty":-4.541134,"marketCap":590367683},{"date":"2024-01-26","current":-9.912818,"twenty":-9.910825,"median":-7.239128,"eighty":-4.565367,"marketCap":591557341},{"date":"2024-02-02","current":-9.937737,"twenty":-9.925728,"median":-7.28225,"eighty":-4.59301,"marketCap":593044413},{"date":"2024-02-09","current":-9.96764,"twenty":-9.966643,"median":-7.362202,"eighty":-4.656903,"marketCap":594828900},{"date":"2024-02-16","current":-1.918771,"twenty":-9.966643,"median":-7.303982,"eighty":-4.541134,"marketCap":114504563},{"date":"2024-02-23","current":-1.649644,"twenty":-9.962656,"median":-7.2641,"eighty":-4.382132,"marketCap":98444182},{"date":"2024-03-01","current":-1.485178,"twenty":-9.942721,"median":-7.216995,"eighty":-4.255363,"marketCap":88629506},{"date":"2024-03-08","current":-1.465243,"twenty":-9.937737,"median":-7.16076,"eighty":-4.202436,"marketCap":87439848},{"date":"2024-03-15","current":-1.515081,"twenty":-9.928955,"median":-7.0934,"eighty":-4.029192,"marketCap":90413992},{"date":"2024-03-22","current":-1.649644,"twenty":-9.912818,"median":-6.924927,"eighty":-3.837326,"marketCap":98444182},{"date":"2024-03-28","current":-1.60479,"twenty":-9.904844,"median":-6.882048,"eighty":-3.54138,"marketCap":95767452},{"date":"2024-04-05","current":-1.493229,"twenty":-9.894877,"median":-6.735572,"eighty":-3.40709,"marketCap":96659696},{"date":"2024-04-12","current":-1.379706,"twenty":-9.873629,"median":-6.531871,"eighty":-3.34002,"marketCap":89311125},{"date":"2024-04-19","current":-1.094567,"twenty":-9.830327,"median":-6.512717,"eighty":-3.300068,"marketCap":70853492},{"date":"2024-04-26","current":-1.048577,"twenty":-9.7389,"median":-6.435973,"eighty":-3.275297,"marketCap":67876455},{"date":"2024-05-03","current":-1.170453,"twenty":-9.714462,"median":-6.384932,"eighty":-3.243335,"marketCap":75765761},{"date":"2024-05-10","current":-1.138196,"twenty":-9.689543,"median":-6.288891,"eighty":-3.200986,"marketCap":73677728},{"date":"2024-05-17","current":-1.025534,"twenty":-9.683563,"median":-6.253159,"eighty":-3.153842,"marketCap":67711920},{"date":"2024-05-24","current":-0.908072,"twenty":-9.651666,"median":-6.21897,"eighty":-3.096311,"marketCap":59956370},{"date":"2024-05-31","current":-0.921625,"twenty":-9.640702,"median":-6.117376,"eighty":-3.032764,"marketCap":60851241},{"date":"2024-06-07","current":-0.944214,"twenty":-9.626747,"median":-6.070923,"eighty":-2.970061,"marketCap":62342693},{"date":"2024-06-14","current":-0.899037,"twenty":-9.612945,"median":-6.014805,"eighty":-2.882965,"marketCap":59359789},{"date":"2024-06-21","current":-0.935179,"twenty":-9.600596,"median":-5.975902,"eighty":-2.800663,"marketCap":61746112},{"date":"2024-06-28","current":-1.007463,"twenty":-9.593379,"median":-5.954462,"eighty":-2.72642,"marketCap":66518759},{"date":"2024-07-05","current":-1.224316,"twenty":-9.576487,"median":-5.902982,"eighty":-2.560948,"marketCap":80836698},{"date":"2024-07-12","current":-1.147514,"twenty":-9.548809,"median":-5.8326,"eighty":-2.429778,"marketCap":75765761},{"date":"2024-07-15","current":-1.165585,"twenty":-9.542228,"median":-5.832059,"eighty":-2.4146,"marketCap":76958923},{"date":"2024-08-02","current":-1.152032,"twenty":-9.535646,"median":-5.831517,"eighty":-2.400893,"marketCap":76064052},{"date":"2024-08-09","current":-1.192692,"twenty":-9.469258,"median":-5.810078,"eighty":-2.273291,"marketCap":78748665},{"date":"2024-08-16","current":-0.47057,"twenty":-9.449136,"median":-5.779362,"eighty":-2.170214,"marketCap":30425620},{"date":"2024-08-23","current":-0.51232,"twenty":-9.447843,"median":-5.727894,"eighty":-2.006011,"marketCap":33125098},{"date":"2024-08-30","current":-0.521551,"twenty":-9.44504,"median":-5.717174,"eighty":-1.838033,"marketCap":33721947},{"date":"2024-09-06","current":-0.475396,"twenty":-9.437737,"median":-5.688753,"eighty":-1.659612,"marketCap":30737703},{"date":"2024-09-13","current":-0.480012,"twenty":-9.395084,"median":-5.681125,"eighty":-1.602796,"marketCap":31036128},{"date":"2024-09-20","current":-0.498474,"twenty":-9.366592,"median":-5.652855,"eighty":-1.557942,"marketCap":32229825},{"date":"2024-09-27","current":-0.486935,"twenty":-9.361608,"median":-5.599013,"eighty":-1.524052,"marketCap":31483764},{"date":"2024-10-04","current":-0.480012,"twenty":-9.336776,"median":-5.546792,"eighty":-1.494379,"marketCap":31036128},{"date":"2024-10-11","current":-0.480012,"twenty":-9.293554,"median":-5.527793,"eighty":-1.485178,"marketCap":31036128},{"date":"2024-10-18","current":-0.475396,"twenty":-9.271899,"median":-5.50278,"eighty":-1.463249,"marketCap":30737703},{"date":"2024-10-25","current":-0.493858,"twenty":-9.268418,"median":-5.485925,"eighty":-1.404343,"marketCap":31931401},{"date":"2024-10-31","current":-0.503089,"twenty":-9.245776,"median":-5.467741,"eighty":-1.384784,"marketCap":32528249},{"date":"2024-11-08","current":-0.507705,"twenty":-9.191651,"median":-5.440937,"eighty":-1.238642,"marketCap":32826674},{"date":"2024-11-15","current":-0.491662,"twenty":-9.159176,"median":-5.335911,"eighty":-1.189981,"marketCap":29842431},{"date":"2024-11-22","current":-0.604745,"twenty":-9.137345,"median":-5.292741,"eighty":-1.17212,"marketCap":36706190},{"date":"2024-11-29","current":-0.822079,"twenty":-9.095067,"median":-5.266277,"eighty":-1.154743,"marketCap":49897746},{"date":"2024-12-06","current":-0.713781,"twenty":-9.047317,"median":-5.253045,"eighty":-1.141948,"marketCap":43324390},{"date":"2024-12-13","current":-0.728549,"twenty":-9.004017,"median":-5.218642,"eighty":-1.13436,"marketCap":44220757},{"date":"2024-12-20","current":-0.625174,"twenty":-8.946955,"median":-5.18424,"eighty":-1.117586,"marketCap":37946190},{"date":"2024-12-27","current":-0.679323,"twenty":-8.795687,"median":-5.159815,"eighty":-1.10594,"marketCap":41232868},{"date":"2025-01-03","current":-0.684246,"twenty":-8.764395,"median":-5.131312,"eighty":-1.091686,"marketCap":41531657},{"date":"2025-01-10","current":-0.639942,"twenty":-8.756375,"median":-5.109656,"eighty":-1.077369,"marketCap":38842557},{"date":"2025-01-17","current":-0.625174,"twenty":-8.753654,"median":-5.065153,"eighty":-1.025534,"marketCap":37946190},{"date":"2025-01-24","current":-0.615329,"twenty":-8.743176,"median":-5.054567,"eighty":-1.007463,"marketCap":37348612},{"date":"2025-01-31","current":-0.575948,"twenty":-8.706848,"median":-5.044823,"eighty":-0.965899,"marketCap":34958301},{"date":"2025-02-07","current":-0.541489,"twenty":-8.666805,"median":-5.038689,"eighty":-0.946021,"marketCap":32866779},{"date":"2025-02-14","current":-0.526721,"twenty":-8.652374,"median":-5.00164,"eighty":-0.932468,"marketCap":31970412},{"date":"2025-02-21","current":-0.556257,"twenty":-8.638152,"median":-4.986004,"eighty":-0.918011,"marketCap":33763145},{"date":"2025-02-28","current":-0.546412,"twenty":-8.61494,"median":-4.906371,"eighty":-0.89994,"marketCap":33165567},{"date":"2025-03-07","current":-0.635019,"twenty":-8.592106,"median":-4.890493,"eighty":-0.87193,"marketCap":38543768},{"date":"2025-03-14","current":-0.694091,"twenty":-8.587408,"median":-4.858736,"eighty":-0.767931,"marketCap":42129234},{"date":"2025-03-21","current":-0.718704,"twenty":-8.568081,"median":-4.787284,"eighty":-0.729534,"marketCap":43623179},{"date":"2025-03-28","current":-0.838362,"twenty":-8.559336,"median":-4.763467,"eighty":-0.729534,"marketCap":43025601},{"date":"2025-04-04","current":-0.821071,"twenty":-8.531837,"median":-4.710422,"eighty":-0.734457,"marketCap":42138208},{"date":"2025-04-11","current":-0.70964,"twenty":-8.523283,"median":-4.675853,"eighty":-0.729459,"marketCap":36419451},{"date":"2025-04-17","current":-0.750694,"twenty":-8.50578,"median":-4.652166,"eighty":-0.7331,"marketCap":38526361},{"date":"2025-04-25","current":-0.756559,"twenty":-8.485618,"median":-4.549017,"eighty":-0.7331,"marketCap":38827348},{"date":"2025-05-02","current":-0.727235,"twenty":-8.4839,"median":-4.504122,"eighty":-0.727235,"marketCap":37322412},{"date":"2025-05-05","current":-0.715505,"twenty":-8.476635,"median":-4.443127,"eighty":-0.727235,"marketCap":36720438}],"updateTime":1746587019585}}}